The newly established Roy Gross Law Firm, LLC, ("RGLaw") is proud to announce the issuance of its first U.S. Patent on January 26, 2016 — U.S. Patent Number 9,242,003 entitled "Surface-Modified Heavy Metal Nanoparticles, Compositions and Uses Thereof.”
The patent is owned by the Israeli company Metallo Therapy, Ltd., and focuses on the company’s revolutionary surface-modified heavy metal nanoparticle particle technology. Metallo Therapy, Ltd. turned to RGLaw to assist in protecting this core technology, which is used during all stages of cancer detection and treatment. Mr. Gross’ expertise in the Chemical and Life Sciences domains was essential to obtain patent protection for Metallo Therapy’s technology in the United States.